Global Haemorrhagic Stroke Drugs Market 2019-2023
Published: Nov 2018 | Pages: 111 | SKU: IRTNTR30243 |
Below are some of the key findings from the hemorrhagic stroke drugs market research report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Get a FREE sample now!
Global hemorrhagic stroke drugs industry overview
The increase in the aging population across the globe is one of the major factors driving the hemorrhagic stroke drugs market growth. Experts within the health care industry have identified that old age is a significant risk factor for several conditions, such as intracerebral hemorrhages. The natural and pathological changes associated with aging can make the cardiovascular system and CNS highly prone to hemorrhagic stroke. Nearly 50 percent of the total intracerebral hemorrhage cases are linked to cerebral amyloid angiopathy (CAA) are found in the elderly population. To address these conditions, pharmacotherapy is being extensively used as a treatment option, including treatment for stroke. Subsequently, there is a huge demand for drugs in this section and is driving the hemorrhagic stroke drugs market growth.
The development of novel therapies for hemorrhagic stroke treatment is one of the significant hemorrhagic stroke drugs market trends. Several potential new treatment approaches are under development or have been developed to offer better therapy to the patients. Few of these that are at the clinical trial stage has begun testing whether regulated blood pressure affects the wellbeing of hemorrhagic stroke patients. Market analysts believe, these therapies once launched will positively drive the market across the globe. The hemorrhagic stroke drugs market forecast report predicts that fueled by these factors, the market will grow at a CAGR of almost 4% during the forecast period.
Top hemorrhagic stroke drugs companies covered in this market research report
The hemorrhagic stroke drugs market is moderately fragmented and in the growth phase. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this hemorrhagic stroke drugs industry analysis report will aid clients to identify and design new growth strategies.
The report offers a complete analysis of various companies including:
- Baxter
- Novartis
- Pfizer
- Sanofi
Hemorrhagic stroke drugs market segmentation based on geographic regions
- Americas
- APAC
- EMEA
Global hemorrhagic stroke drugs market analysis reveals that the Americas will lead the hemorrhagic stroke drugs market share until 2023. However, the APAC region will account for the highest hemorrhagic stroke drugs market growth throughout the forecast period.
Hemorrhagic stroke drugs market segmentation based on products
- Antihypertensives
- Anticoagulants
- Diuretics
- Anticonvulsants and others
The antihypertensives segment will dominate the hemorrhagic stroke drugs market share during the forecast period. Antihypertensives will also account for the highest hemorrhagic stroke drugs market growth. Additionally, the report also provides an accurate prediction of the contribution of the various product segments to the growth of the hemorrhagic stroke drugs market size.
Key highlights of the global hemorrhagic stroke drugs market for the forecast years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the hemorrhagic stroke drugs market during the next five years
- Precise estimation of the global hemorrhagic stroke drugs market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- Growth of the hemorrhagic stroke drugs industry across the Americas, APAC, and EMEA
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details on the factors that will challenge the growth of hemorrhagic stroke drugs companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: PIPELINE ANALYSIS
PART 05: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Antihypertensives - Market size and forecast 2018-2023
- Anticoagulants - Market size and forecast 2018-2023
- Diuretics - Market size and forecast 2018-2023
- Anticonvulsants and others - Market size and forecast 2018-2023
- Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY TYPE
PART 10: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Americas - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- EMEA - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Baxter
- Novartis
- Pfizer
- Sanofi
PART 16: APPENDIX
- Research methodology
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis